A 60-year-old patient presented with neurological symptoms which proved to be a paraneoplastic syndrome secondary to a small-cell lung cancer. The investigations and treatment for these syndromes are discussed. The patient improved with high dose steroids and chemotherapy.
GrausFCordon-CardoCPosnerJ. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology1985; 35: 538–43.
6.
GraufFKeime-GuibertFReneR. Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients. Brain2001;124:1138–48.
7.
GómezMZarranzJ. Central hypoventilation as the presenting symptom in Hu associated paraneoplastic encephalomyelitis, J Neurol Neurosurg Psychiatry2007;78:1143–45.
TitulaerMWirtzPDalmauJ. Screening for tumours in paraneoplastic syndromes: Report of an EFNS taskforce. Eur J Neurol2011;18:19–e3.
10.
GrausFKeime-GuibertF. Anti-Hu-associated encephalomyelitis: Analysis of 200 patients. Brain2001;124:1138–48.
11.
CandlerPHartP. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry2004;75:1411–15.
12.
Shams'iliSGrefkensJde LeeuwB. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: Analysis of 50 patients. Brain2003;126:1409–18.
13.
GiomettoBVitalianiRLindeck-PozzaE. Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev2012;(12)CD007625.
14.
GreenleeJ. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol2013;15:185–200.
